Derek Daw, Chief Technology Officer

Derek Daw has over 30 years of experience in medical device research and development. He graduated with an Engineering degree from University of California, Irvine. He has a long history of supporting initial clinical trials in both US and international locations and developing strong relationships with clinical KOL’s. He is experienced at taking the product from the lab into the first clinical cases and working with clinicians to identify product strengths and weaknesses. His experience includes developing products at large companies, (Edwards LifeSciences and Bard) as well as several small startup companies that brought their products through initial clinical studies to commercialization. He worked to support the sale of InterTherapy Inc. to CVIS (became Boston Scientific), Neuro Navigational Inc. to NeuroCare, Endovascular Inc. to ESC Medical Systems, and SenoRx Inc. to C.R. Bard (now BD). His technology experience has been focused on products that include capital equipment and disposables. Derek’s technology experience includes; intravascular ultrasound and therapeutic oxygen treatment sold to interventional cardiologists, neuro endoscopy for pediatric neurologists, varicose vein treatment for vascular surgeons, and breast care products for radiologists and breast surgeons. As Vibrato’s CTO, he developed the first wearable therapeutic ultrasound device for the treatment of PAD and is working to move that product into clinical studies and FDA clearance.